Artemis Therapeutics, Inc. – ‘10-K’ for 12/31/20 – ‘EX-101.CAL’

On:  Tuesday, 3/30/21, at 1:26pm ET   ·   For:  12/31/20   ·   Accession #:  1178913-21-1229   ·   File #:  0-24431

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    317K 
 2: EX-31.1     Certification -- §302 - SOA'02 -- exhibit_31-1      HTML     17K 
 3: EX-32.1     Certification -- §906 - SOA'02 -- exhibit_32-1      HTML     14K 
10: R1          Document and Entity Information                     HTML     51K 
11: R2          Consolidated Balance Sheet                          HTML     72K 
12: R3          Consolidated Balance Sheet (Parenthetical)          HTML     33K 
13: R4          Consolidated Statement of Operation                 HTML     42K 
14: R5          Consolidated Statements of changes of               HTML     35K 
                shareholder's equity (Deficiency)                                
15: R6          Consolidated Statement of Cash Flows                HTML     45K 
16: R7          General                                             HTML     22K 
17: R8          Significant Accounting Policies                     HTML     27K 
18: R9          Commitments and Contingencies                       HTML     17K 
19: R10         Income Tax                                          HTML     42K 
20: R11         Warrants Issued to Investors                        HTML     19K 
21: R12         Computation of Net Loss per Share                   HTML     29K 
22: R13         Stock Capital                                       HTML     57K 
23: R14         Related Parties                                     HTML     17K 
24: R15         Subsequent Events                                   HTML     16K 
25: R16         Significant Accounting Policies (Policies)          HTML     49K 
26: R17         Income Tax (Tables)                                 HTML     38K 
27: R18         Warrants Issued to Investors (Tables)               HTML     20K 
28: R19         Computation of Net Loss per Share (Tables)          HTML     28K 
29: R20         Stock Capital (Tables)                              HTML     53K 
30: R21         Commitments and Contingencies (Details)             HTML     18K 
31: R22         Income Tax (Narrative) (Details)                    HTML     21K 
32: R23         Income Tax (Schedule of Deferred Income Taxes)      HTML     19K 
                (Details)                                                        
33: R24         Income Tax (Schedule of Net Operating Loss          HTML     18K 
                Carryforwards) (Details)                                         
34: R25         Warrants Issued to Investors (Details)              HTML     19K 
35: R26         Computation of Net Loss per Share (Schedule of      HTML     35K 
                Calculation of Basic Loss Per Share) (Details)                   
36: R27         Stock Capital (Narrative) (Details)                 HTML     42K 
37: R28         Stock Capital (Summary of Stock Option Activity)    HTML     41K 
                (Details)                                                        
38: R29         Stock Capital (Summary of Stock Option Exercise     HTML     30K 
                price) (Details)                                                 
39: R30         Related Parties (Narrative) (Details)               HTML     23K 
41: XML         IDEA XML File -- Filing Summary                      XML     71K 
40: EXCEL       IDEA Workbook of Financial Reports                  XLSX     40K 
 4: EX-101.INS  XBRL Instance -- atms-20201231                       XML    488K 
 6: EX-101.CAL  XBRL Calculations -- atms-20201231_cal               XML     70K 
 7: EX-101.DEF  XBRL Definitions -- atms-20201231_def                XML    211K 
 8: EX-101.LAB  XBRL Labels -- atms-20201231_lab                     XML    433K 
 9: EX-101.PRE  XBRL Presentations -- atms-20201231_pre              XML    325K 
 5: EX-101.SCH  XBRL Schema -- atms-20201231                         XSD     82K 
42: ZIP         XBRL Zipped Folder -- 0001178913-21-001229-xbrl      Zip     57K 

‘EX-101.CAL’   —   XBRL Calculations — atms-20201231_cal

This Exhibit is an XBRL XML File.

7 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/19/19  Manuka, Inc.                      10-Q        6/30/19   43:2.4M                                   Z-K Global Ltd./FA
10/25/17  Manuka, Inc.                      8-K:1,3,5,910/25/17    4:558K                                   Z-K Global Ltd./FA
 8/29/16  Manuka, Inc.                      8-K:1,2,3,5 8/29/16    5:1M                                     Z-K Global Ltd./FA
 8/09/11  Artemis Therapeutics, Inc.        DEF 14A     8/09/11    1:626K                                   Z-K Global Ltd./FA
 9/24/10  Artemis Therapeutics, Inc.        8-K:5,9     9/24/10    5:52K                                    Z-K Global Ltd./FA
 4/04/08  Artemis Therapeutics, Inc.        8-K:5,9     4/04/08    2:5K                                     Z-K Global Ltd./FA
11/14/02  Artemis Therapeutics, Inc.        10QSB       9/30/02    6:113K                                   Bowne & C… Smartedgar/FA